Lunai Bioworks Current Ratio 2013-2025 | LNAI
Lunai Bioworks current ratio from 2013 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Lunai Bioworks Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $0.00B | $0.03B | 0.04 |
| 2025-03-31 | $0.00B | $0.03B | 0.13 |
| 2024-12-31 | $0.00B | $0.03B | 0.06 |
| 2024-09-30 | $0.00B | $0.02B | 0.09 |
| 2024-06-30 | $0.00B | $0.03B | 0.07 |
| 2024-03-31 | $0.00B | $0.02B | 0.06 |
| 2023-12-31 | $0.00B | $0.01B | 0.18 |
| 2023-09-30 | $0.00B | $0.01B | 0.19 |
| 2023-06-30 | $0.00B | $0.01B | 0.23 |
| 2023-03-31 | $0.00B | $0.01B | 0.33 |
| 2022-12-31 | $0.01B | $0.01B | 0.48 |
| 2022-09-30 | $0.01B | $0.01B | 1.14 |
| 2022-06-30 | $0.01B | $0.01B | 1.48 |
| 2022-03-31 | $0.01B | $0.01B | 1.56 |
| 2021-12-31 | $0.02B | $0.01B | 2.36 |
| 2021-09-30 | $0.02B | $0.00B | 12.77 |
| 2021-06-30 | $0.02B | $0.00B | 11.08 |
| 2021-03-31 | $0.01B | $0.00B | 3.49 |
| 2020-12-31 | $0.00B | $0.00B | 2.57 |
| 2020-09-30 | $0.01B | $0.00B | 7.29 |
| 2020-06-30 | $0.01B | $0.00B | 6.70 |
| 2020-03-31 | $0.01B | $0.00B | 11.60 |
| 2019-12-31 | $0.01B | $0.00B | 8.31 |
| 2019-09-30 | $0.01B | $0.00B | 8.62 |
| 2019-06-30 | $0.01B | $0.00B | 11.25 |
| 2019-03-31 | $0.01B | $0.00B | 6.92 |
| 2018-12-31 | $0.01B | $0.00B | 8.10 |
| 2018-09-30 | $0.01B | $0.00B | 17.26 |
| 2018-06-30 | $0.02B | $0.00B | 18.04 |
| 2018-03-31 | $0.02B | $0.00B | 18.83 |
| 2017-12-31 | $0.01B | $0.01B | 1.21 |
| 2017-09-30 | $0.00B | $0.00B | 3.32 |
| 2017-06-30 | $0.00B | $0.00B | 1.41 |
| 2017-03-31 | $0.00B | $0.00B | 0.12 |
| 2016-12-31 | $0.00B | $0.00B | 0.20 |
| 2016-09-30 | $0.00B | $0.00B | 0.56 |
| 2016-06-30 | $0.00B | $0.00B | 0.49 |
| 2016-03-31 | $0.00B | $0.00B | 0.80 |
| 2015-12-31 | $0.00B | 0.00 | |
| 2015-09-30 | $0.00B | $0.00B | 1.55 |
| 2015-03-31 | $0.00B | 0.00 | |
| 2014-12-31 | $0.00B | 0.00 | |
| 2014-09-30 | $0.00B | $0.01B | 0.48 |
| 2014-06-30 | $0.00B | $0.00B | 0.13 |
| 2013-12-31 | $0.00B | $0.00B | 0.07 |
| 2013-09-30 | $0.00B | 0.00 | |
| 2013-06-30 | $0.00B | 0.00 | |
| 2012-12-31 | $0.00B | $0.00B | 0.05 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.025B | $0.000B |
| Lunai Bioworks Inc. is an AI-powered drug discovery and biodefense company. Lunai Bioworks Inc., formerly known as RENOVARO INC, is based in LOS ANGELES. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.084B | 58.67 |
| Tempus AI (TEM) | United States | $12.183B | 0.00 |
| Doximity (DOCS) | United States | $9.342B | 38.47 |
| Hims & Hers Health (HIMS) | United States | $8.418B | 68.48 |
| IRhythm Technologies (IRTC) | United States | $5.504B | 0.00 |
| Hinge Health (HNGE) | United States | $3.224B | 0.00 |
| Privia Health (PRVA) | United States | $2.884B | 180.38 |
| Inspire Medical Systems (INSP) | United States | $2.509B | 41.51 |
| Heartflow (HTFL) | United States | $2.383B | 0.00 |
| 10x Genomics (TXG) | United States | $2.011B | 0.00 |
| Enovis (ENOV) | United States | $1.715B | 9.01 |
| Omnicell (OMCL) | United States | $1.576B | 32.22 |
| Azenta (AZTA) | United States | $1.364B | 59.50 |
| Phreesia (PHR) | United States | $1.304B | 0.00 |
| Schrodinger (SDGR) | United States | $1.299B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.900B | 0.00 |
| Claritev (CTEV) | United States | $0.715B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 108.33 |
| Butterfly Network (BFLY) | United States | $0.536B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.466B | 0.00 |
| Carlsmed (CARL) | United States | $0.349B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.05 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.239B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.212B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.172B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.160B | 0.00 |
| CareCloud (CCLD) | United States | $0.133B | 7.28 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.085B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.045B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.031B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |